Related Experiment Video
Updated: Mar 26, 2026
10:04
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
19.4K
[Drug-resistant tuberculosis. Epidemiology, diagnostics and therapy]
M P Grobusch1,2, F Schaumburg3, E Altpeter4
1Zentrum für Tropen- und Reisemedizin, Abteilung Infektiologie, Akademisch-Medizinisches Zentrum, Universität von Amsterdam, 22660, 1100 DD, Amsterdam, Niederlande. m.p.grobusch@amc.uva.nl.
Der Internist
|January 23, 2016
Summary
Drug-resistant tuberculosis (DR-TB) poses a global health challenge. This review covers DR-TB epidemiology, diagnostics, and treatment, with a focus on Germany, Switzerland, and Austria, and highlights current research.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Drug-resistant tuberculosis (DR-TB) represents a significant global health threat.
- The increasing prevalence of DR-TB complicates tuberculosis control efforts worldwide.
Purpose of the Study:
- To provide a concise overview of the global epidemiology, diagnostics, and treatment of DR-TB.
- To detail the specific situation of DR-TB in Germany, Switzerland, and Austria.
- To outline current research directions in the field of resistant tuberculosis.
Main Methods:
- Literature review of global epidemiology, diagnostics, and treatment strategies for DR-TB.
- Focused analysis of DR-TB data from Germany, Switzerland, and Austria.
- Synthesis of current research trends and challenges in combating resistant TB.
Main Results:
- Global DR-TB epidemiology, diagnostic approaches, and treatment modalities are summarized.
- Specific insights into the DR-TB landscape in Germany, Switzerland, and Austria are presented.
- Key areas of ongoing research in resistant TB are identified.
Conclusions:
- Effective global strategies for DR-TB management require understanding regional variations.
- Continued research is crucial for developing novel diagnostics and treatments for resistant TB.
- The situation in Germany, Switzerland, and Austria provides valuable case studies for broader DR-TB control.
Related Concept Videos
01:28Pulmonary Tuberculosis V
768
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
768
01:26Pulmonary Tuberculosis IV
632
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
632
01:29Pulmonary Tuberculosis I
1.2K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
01:31Pulmonary Tuberculosis III
1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.3K
01:28Pulmonary Tuberculosis II
2.0K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.0K
01:29Therapeutic Drug Monitoring: Affecting Factors
325
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
325